Soft-tissue sarcoma: overview, types, diagnosis and management

Characteristics and common types

STS vary in appearance and aggressiveness depending on cell type and anatomical site. Some of the frequently encountered subtypes include:

• Liposarcoma (fat cells)
• Leiomyosarcoma (smooth muscle)
• Synovial sarcoma (often near joints)
• Angiosarcoma (blood vessel lining)
• Malignant peripheral nerve sheath tumor
• Undifferentiated pleomorphic sarcoma

Pathologic examination, immunohistochemistry and increasingly molecular tests are used to distinguish these entities and guide management. For general context about sarcoma classification see sarcoma resources.

Diagnosis and staging

Evaluation usually begins with imaging — MRI for limbs and soft tissues, CT for abdominal or thoracic disease — followed by biopsy to obtain tissue for definitive diagnosis. Staging considers tumor size, depth, histologic grade and presence of metastases, with the lungs being a common site of spread. Accurate histologic typing and grading are essential for prognosis and treatment planning.

Treatment and follow-up

Surgery with clear margins is the cornerstone of local control. Radiation therapy is commonly used before or after surgery to reduce local recurrence. Systemic chemotherapy may be recommended for high-grade tumors, certain subtypes or metastatic disease. Targeted agents and newer systemic therapies are available for some molecularly defined sarcomas. Multidisciplinary care at specialist centers improves outcomes, and long-term surveillance is important because recurrences can occur years after initial treatment.

Importance and notable facts

Soft-tissue sarcomas are heterogeneous and require individualized treatment plans. Referral to a specialist center, consideration of clinical trials and integration of surgical, medical and radiation oncology expertise are key features of contemporary care. Research into molecular drivers continues to refine diagnosis and expand targeted treatment options.